iCAD's VividLook


September 16, 2009 - iCAD Inc. will host a series of educational events designed for radiologists, urologists, oncologists, radiation oncologists, surgeons, technologists and other referring physicians who diagnose and treat patients with prostate cancer.

Two webinars, entitled “Prostate MRI – A Paradigm Shift in Prostate Cancer Diagnosis and Management” will focus on how MRI combined with an advanced quantitative image analysis software solution, (iCAD’s VividLook), supports improved prostate cancer management. The course will include clinical case reviews that will demonstrate prostate cancer detection in patients with previously negative prostate biopsy and rising PSA, as well as the use of dynamic contrast enhanced (DCE) MRI and Computer-Aided Detection (CAD) to monitor prostate cancer response to radiation therapy.

They will be held on:
· October 15, 2009, at noon ET, with Dr. François Cornud, diagnostic and interventional radiologist at the Centre d’Imagerie Tourville
· November 10, 2009, at 3 pm ET, with Dr. Russell Low, medical director at Sharp and Children’s MRI Center and Assistant Clinical Professor at the University of California San Diego School of Medicine.

In addition, a non-RSNA satellite symposium will be held on Tuesday, December 1, 2009 at 7am CT at the Hyatt Regency in Chicago, room CC24BC. The session, “How quantitative image analysis CAD and MRI play an integral role in prostate cancer programs including pre-biopsy guidance, treatment planning, active surveillance and therapy response monitoring,” will include presentations by clinical experts, Dr. Cornud and Dr. Low. Specific focus areas include how DCE MRI in conjunction with other MRI imaging techniques can improve the sensitivity and specificity of prostate cancer localization and detection as compared to current imaging practices. Specific case examples will be shared, including how DCE MRI and CAD support improved treatment planning for patients undergoing Cyberknife therapy.

For more information: www.icadmed.com

Related Content

News | Computed Tomography (CT)

October 14, 2021 — Cardiac computed tomography angiography (CTA) derived left atrium emptying fraction (LAEF) improves ...

Time October 14, 2021
arrow
News | Radiation Therapy

October 7, 2021 — ViewRay, Inc. announced that the company has received acceptance from the FDA on their recent ...

Time October 07, 2021
arrow
Feature | Cardiac Imaging

October 6, 2021 – A new study published in Radiology: Cardiothoracic Imaging on cardiac imaging trends over a decade ...

Time October 06, 2021
arrow
Feature | Computed Tomography (CT) | By Dave Fornell, ITN Editor

The U.S. Food and Drug Administration (FDA) cleared the world's first photon-counting computed tomography (CT) scanner ...

Time October 04, 2021
arrow
News | Radiology Business

September 27, 2021 — Esaote, an Italian company leader in the biomedical equipment sector – ultrasound, MRI and software ...

Time September 27, 2021
arrow
News | Prostate Cancer

September 24, 2021 — Scientists have identified two subtypes of metastatic prostate cancer that respond differently to ...

Time September 24, 2021
arrow
News | Cardiac Imaging

September 22, 2021 — Test selection should be a shared decision between patient and physician rather than directed by ...

Time September 23, 2021
arrow
News | Digital Pathology

September 22, 2021 — The U.S. Food and Drug Administration authorized marketing of software to assist medical ...

Time September 22, 2021
arrow
News | Magnetic Resonance Imaging (MRI)

September 20, 2021 — Gadolinium-based contrast agents, the gold standard in magnetic resonance imaging (MRI) to ...

Time September 20, 2021
arrow
News | Radiopharmaceuticals and Tracers

September 17, 2021 — Blue Earth Diagnostics, a Bracco company and recognized leader in the development and ...

Time September 17, 2021
arrow
Subscribe Now